use of rifaximin and rifaximin containing pharmaceutical compositions for the treatment of helicobacter pylori related magendyspepsie

• 1. 包含利福昔明的药物组合物、其制备方法及其在治疗阴道感染中的应用 [P] . 中国专利： CN103732212B . 2016.06.01
• 2. 包含利福昔明的药物组合物、其制备方法及其在治疗阴道感染中的应用 [P] . 中国专利： CN103732212A . 2014-04-16
• 3. use of rifaximin and rifaximin containing pharmaceutical compositions for the treatment of helicobacter pylori related magendyspepsie [P] . 德国专利： DE69400493D1 . 1996-10-17

  机译： 利福昔明和含有利福昔明的药物组合物在治疗幽门螺杆菌相关的乳源性消化不良中的用途

• 4. Use of rifaximin and rifaximin - containing pharmaceutical compositions for the treatment of the stomach dyspepsia caused by helicobacter pylori [P] . 德国专利： DE69400493T2 . 1997-01-23

  机译： 利福昔明和含有利福昔明的药物组合物在治疗由幽门螺杆菌引起的胃消化不良中的用途

• 5. RIFAXIMIN AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT IN THE TREATMENT OF GASTRIC DYSPEPSIA CAUSED BY HELICOBACTER PYLORI [P] . CA2115381C . 1999-01-05

  机译： 利福昔明及其药物组合物治疗幽门螺杆菌引起的消化不良

• 1. Rifaximin-Cefacetril Treatments of Clinical Mastitis: Efficacy of One-day Treatment Compared to Two-day Treatment [C] . Annual Meeting of The National Mastitis Council (U.S.). . 2018
• 2. Rifaximin-mediated changes to the epithelial cell proteome: 2-D gel analysis. [D] . Schrodt, Caroline. 2012
• 3. Therapeutic efficacy of amoxicillin and rifaximin in patients with small intestinal bacterial overgrowth and Helicobacter pylori infection [O] . Paulina Konrad, Jan Chojnacki, Anita Gąsiorowska, 2018
• 4. Efficacy of Levofloxacin and Rifaximin based Quadruple Therapy in Helicobacter pylori Associated Gastroduodenal Disease: A Double-Blind, Randomized Controlled Trial [O] . Choi, Kang Hyun, Chung, Woo Chul, Lee, Kang-Moon, 2011

• 1. Effect of rifaximin on gut microbiota composition in advanced liver disease and its complications [J] . Francesca Romana Ponziani ,Viviana Gerardi ,Silvia Pecere . 世界胃肠病学杂志：英文版 . 2015,第43期
• 2. Efficacy of long-term rifaximin treatment for hepatic encephalopathy in the Japanese [J] . Shinya Nishida ,Koichi Hamada ,Noriyuki Nishino . 世界肝病学杂志：英文版（电子版） . 2019,第6期
• 3. Rifaximin in the treatment of inflammatory bowel disease [J] . Mario Guslandi . 世界胃肠病学杂志：英文版 . 2011,第42期
• 4. Chemical Composition of the Essential Oil of Mastic Gum and their Antibacterial Activity Against Drug-Resistant Helicobacter pylori [J] . Tomofumi Miyamoto ,Tadayoshi Okimoto ,Michihiko Kuwano . 应用天然产物(英文) . 2014,第4期
• 5. Analysis of the Effect of Different Treatment Schemes on Helicobacter Pylori Infection on Improving the Quality of Life of Patients [J] . Zhi Zong . 抗癌研究 . 2021,第001期
• 6. 利福昔明治疗肠易激综合征疗效与安全性的Meta分析 [C] . 王霄腾 ,戴金锋 ,吕宾 . 世界中医药学会联合会消化病专业委员会第六届消化病国际学术大会 . 2015
• 7. 利福昔明对奶牛乳源性金黄色葡萄球菌及其生物被膜体外抑制作用研究 [A] . 安冉 . 2018